Arthritis and rheumatism
-
Arthritis and rheumatism · Sep 2011
Randomized Controlled Trial Multicenter StudyPredicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.
To identify baseline characteristics of patients with scleroderma-related interstitial lung disease (SSc-ILD) that could serve as predictors of the most favorable response to 12-month treatment with oral cyclophosphamide (CYC). ⋯ A retrospective analysis of the Scleroderma Lung Study data identified the severity of reticular infiltrates on baseline HRCT and the baseline MRSS as patient features that might be predictive of responsiveness to CYC therapy.